CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ARCT

ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine

Phase 3
Arcturus Therapeutics Holdings Inc. (ARCT)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in COVID-19 Vaccines

View Full Landscape
Drug Information

Target Indication

COVID-19 Vaccines

Clinical Trial

NCT05012943

Last updated: 9/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.